Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Topical Minoxidil is effective for hair loss after COVID-19.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

The pandemic increased stress-related skin conditions and those affected by behavior changes.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.